title: CA125 screening after risk-reducing salpingo-oophorectomy: are the titers too high, or is it all just too much?
authors.forename: Leslie S
authors.initials: LS
authors.lastname: Bradford
authors.forename: John O
authors.initials: JO
authors.lastname: Schorge
mesh_terms: D000328:Adult; D001943:Breast Neoplasms / Q000235:genetics / Q000517:prevention & control* / Q000601:surgery; D018394:CA-125 Antigen / Q000097:blood*; D002277:Carcinoma / Q000235:genetics / Q000517:prevention & control* / Q000601:surgery; D005187:Fallopian Tubes / Q000601:surgery*; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D006801:Humans; D015994:Incidence; D008565:Membrane Proteins / Q000097:blood*; D009154:Mutation; D010051:Ovarian Neoplasms / Q000235:genetics / Q000517:prevention & control* / Q000601:surgery; D010052:Ovariectomy; D010534:Peritoneal Neoplasms / Q000453:epidemiology / Q000235:genetics
chemical_list: D018394:CA-125 Antigen; C451759:MUC16 protein, human; D008565:Membrane Proteins